BioTech Nation ... with Dr. Moira Gunn
Welcome to BIOTECH NATION !!.
Moira Gunn · BioTech Nation Team
Show overview
BioTech Nation ... with Dr. Moira Gunn has been publishing since 2022, and across the 4 years since has built a catalogue of 176 episodes. That works out to roughly 60 hours of audio in total. Releases follow a weekly cadence.
Episodes typically run ten to twenty minutes — most land between 14 min and 25 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.
The show is actively publishing — the most recent episode landed 1 weeks ago, with 26 episodes already out so far this year. The busiest year was 2025, with 50 episodes published. Published by BioTech Nation Team.
From the publisher
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
Latest Episodes
View all 176 episodesLooking Forward: Biotech in the Balance? Dr. Jeremy Levin, Bioentrepreneur & Former Chair, BIO
From 200 Snake Bites to a Biotech Breakthrough in Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax
Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
Personalized Vaccines for Treating Glioblastoma? Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
A Life Decoded...A 2007 Interview with Dr. J. Craig Venter
50 Years of Genentech...Ashley Magargee, CEO, Genentech
The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio
New treatment being tested for pre-term babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
Ep 26014Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment.
Ep 26013Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation...want to go to space? Well...it's never too late to follow your dreams, and Tech Nation Health Chief Correspondent Dr. Daniel Kraft joins us to talk about who could medically qualify to climb aboard and rocket into orbit. His answers may surprise you...
Ep 26012Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
On this week's BioTech Nation...what could the future of American Healthcare look like? Moira speaks with Dr. Marschall Runge, University of Michigan Medical School Professor, about how Big Tech is quickly redefining the entire healthcare system. His book is, “The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine.”
Ep 26011Regaining Function After Spinal Cord Injury: A New Path Forward? Dr. Adam Rogers, CEO, NervGen Pharma
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial participants have seen increased function as much as 10 years post-trauma.
Ep 26010A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics
On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and Frontotemporal Dementia.
Ep 26009The Future of Early Cancer Screening...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
What if you could routinely screen for early cancer, detecting it while it's easier to treat? Tech Nation Health Chief Correspondent, Dr. Daniel Kraft discusses the latest diagnostics that could allow us to do just that. From blood tests to full-body scans, the future of cancer screening could mean finding cancer before obvious symptoms even begin...
Ep 26008AI in the Exam Room, Dr. Robert Wachter, Author, "A Giant Leap"
On this week’s Biotech Nation, how doctors and hospitals are using AI, and how it could change the practice of medicine. Moira speaks with Dr. Robert Wachter about his book, “A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future”.
Ep 26007ChatGPT...for Healthcare? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
You may already use "Dr. ChatGPT" to answer your medical questions... but now, OpenAI has announced the rollout of ChatGPT Health and OpenAI for Healthcare. Dr. Daniel Kraft has the latest on how each platform will work, and what happens with the health data you share.